PHIO

Phio Pharmaceuticals Corp Cross-source read$1.03 1.98%
Health CareCUSIP 71880W501· EOD Sep 11, 2026

Among active 13F managers last quarter, 4 opened and 3 added, while none reduced or exited; the largest holder to move was Citadel Advisors LLC (new position). Over the last 180 days, 2 insiders bought and none sold, a net +$38K in open-market trades.

Tracked 13F holders
20
4 in Q2 2026 filings
13F value (tracked)
$670K
Smart-money readBullish
Net sellingNet buying
Funds · active managers, latest 13F
7 adding · 0 trimming
Insiders · Form 4 open-market, 180d
2 buying · 0 selling · +$38K
US House · STOCK Act, 180d
0 buying · 0 selling

Funds lean in and no leg opposes.

Price & smart-money activity

$1.03 1.98%5Y -99.5%
$0.82$69.12$137.43$205.73$274.03202120222023202420252026832222622238222
Hover for who · click for detailEnd-of-day closing prices52w $0.86 – $2.48

Who owns PHIO?

20 tracked 13F filers · ranked by shares held

20 tracked 13F filers disclose a position in PHIO as of the latest SEC 13F filings, a combined $670K in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

#FundSharesPosition valueLast moveAs ofHistory
1Jane Street Group, LLC119K
$145K
New
+119K sh
Q1 2026
2Geode Capital Management, LLC115K
$117K
−22%
Reduced · −33K sh
Q2 2026
3Vanguard Capital Management LLC94K
$97K
+18%
Added · +14K sh
Q2 2026
4Citadel Advisors LLC47K
$48K
New
+47K sh
Q2 2026
5Cetera Investment Advisers45K
$55K
+5.9%
Added · +3K sh
Q1 2026
6Vanguard Fiduciary Trust Co38K
$39K
Held
Q2 2026
7Two Sigma Investments, LP32K
$40K
+124%
Added · +18K sh
Q1 2026
8UBS Group AG27K
$33K
+214%
Added · +18K sh
Q1 2026
9XTX Topco Ltd25K
$30K
New
+25K sh
Q1 2026
10Northern Trust Corp24K
$29K
Held
Q1 2026
11Bridgeway Capital Management, LLC12K
$12K
New
+12K sh
Q2 2026
12Tower Research Capital LLC (TRC)8K
$9K
New
+8K sh
Q1 2026
13Morgan Stanley6K
$7K
Held
Q1 2026
14Osaic Holdings, Inc.2K
$2K
New
+2K sh
Q1 2026
15Spire Wealth Management2K
$2K
New
+2K sh
Q1 2026
16SBI Securities Co., Ltd.1K
$1K
+1.9%
Added · +23 sh
Q2 2026
17Citigroup Inc1K
$1K
New
+1K sh
Q1 2026
18AssetMark, Inc110
$113
Held
Q2 2026
19Activest Wealth Management9
$9
Held
Q2 2026
20Caitong International Asset Management Co., Ltd6
$6
+100%
Added · +3 sh
Q2 2026

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Is PHIO being bought or sold by institutions?

Last quarter, 4 funds opened a new position in PHIO and 3 added to an existing one, while none reduced or exited. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).

Opened
4
funds took a first position
Added
3
added to an existing position
Biggest moves · ranked by size of the change, positions above a floor

Funds that own PHIO also own

CompanyCo-held byTheir position there
Nvidia CorpNVDA7 funds$4.9B
Amazon.com IncAMZN7 funds$4.1B
Apple IncAAPL7 funds$3.9B
Alphabet Inc-CL AGOOGL7 funds$2.5B
Tesla IncTSLA7 funds$1.8B
JPMorgan Chase & CoJPM7 funds$1.8B
Berkshire Hathaway Inc-CL BBRK/B7 funds$1.4B
Costco Wholesale CorpCOST7 funds$1.4B
Advanced Micro DevicesAMD7 funds$1.4B
Eli Lilly & CoLLY7 funds$1.3B
Lam Research CorpLRCX7 funds$973.1M
Applied Materials IncAMAT7 funds$970.9M

Ranked by how many of PHIO's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in PHIO.

Insider activity (Form 4)

Full insider page →
Buys · 180d
$38K
2 insiders
Net · 180d
$38K
3 open-market transactions
DateInsiderRoleActionSharesValue
Aug 19, 2026Plott Ronald ToddDirectorBuy (P)15K$17K
Aug 18, 2026Bitterman Robert JChairman, Pres. & CEO, DirectorBuy (P)10K$11K
Jun 26, 2026Bitterman Robert JChairman, Pres. & CEO, DirectorBuy (P)10K$10K
Dec 31, 2025Bitterman Robert JChairman, Pres. & CEO, DirectorBuy (P)5K$5K
Dec 23, 2025Bitterman Robert JChairman, Pres. & CEO, DirectorBuy (P)5K$5K
Nov 21, 2025Bitterman Robert JChairman, Pres. & CEO, DirectorBuy (P)5K$6K
Nov 18, 2025Bitterman Robert JChairman, Pres. & CEO, DirectorBuy (P)5K$6K
Jun 10, 2025Bitterman Robert JChairman, Pres & CEO, DirectorBuy (P)2K$5K
Jun 10, 2025Ferrara Robert LDirectorBuy (P)3K$6K
Jun 9, 2025Bitterman Robert JChairman, Pres & CEO, DirectorBuy (P)2K$4K
May 22, 2025Bitterman Robert JChairman, Pres & CEO, DirectorBuy (P)1K$2K
May 21, 2025Bitterman Robert JChairman, Pres & CEO, DirectorBuy (P)3K$5K

Do institutions, insiders and Congress agree?

Confluence: insiders and funds buying

Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.

SEC EDGAR 13F + Form 4 + US House STOCK Act{ }get_ticker_confluence · API & MCP

Signals by source

Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive

SourceBuyingSellingNet
13F funds
Top 100 holders by value, passive included; the hero counts active managers only
61
Insiders
Form 4 open-market
20+$38K
US House
STOCK Act trades
00$0
Sector rotation
PHIO is in Health Care, which smart money is rotating OUT OF
$5.0B

Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.

Institutional ownership over time

4 tracked filers in Q2 2026 filingsstill filing
01121Q3 2024Q1 2025Q3 2025Q1 2026Q2 2026
tracked filers holding their reported valueQ2 2026 filings so far: $119K
Each bar counts tracked filers with a position in that quarter's filings, so the newest bar excludes filers still on an earlier quarter. Arkolith's tracked universe has grown over this window; part of any long-run rise is coverage, not new buyers.

Recent filings

15 most recent

Keep exploring

Connected entities for PHIO

Browse more

Build

Ask your agent what changed in PHIO

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/PHIO/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for PHIO.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for PHIO. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.